Melphalan, Peripheral Stem Cell Transplantation, and Interleukin-2 Followed by Interferon Alfa in Treating Patients With Advanced Multiple Myeloma

This study has been completed.

Study NCT00006244 Information provided by Fred Hutchinson Cancer Research Center

First Received: September 11, 2000 Last Updated: October 1, 2010 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Primary Completion Date:	June 2008 (Final data collection date for primary outcome measure)